Prediction of Therapeutic Effect of Chemotherapy for NSCLC Using Dual-Input Perfusion CT Analysis: Comparison among Bevacizumab Treatment, Two-Agent Platinum-based Therapy without Bevacizumab, and Other Non-Bevacizumab Treatment Groups.

scientific article published on 23 October 2017

Prediction of Therapeutic Effect of Chemotherapy for NSCLC Using Dual-Input Perfusion CT Analysis: Comparison among Bevacizumab Treatment, Two-Agent Platinum-based Therapy without Bevacizumab, and Other Non-Bevacizumab Treatment Groups. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1148/RADIOL.2017162204
P698PubMed publication ID29059037

P50authorKoji SagiyamaQ84594174
Hidetake YabuuchiQ88410683
H HondaQ88632968
Takeshi KamitaniQ90840626
Yuzo YamasakiQ94485961
Satoshi KawanamiQ114440698
P2093author name stringIsamu Okamoto
Eiji Iwama
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectbevacizumabQ413299
non-small-cell lung carcinomaQ3658562
P304page(s)685-695
P577publication date2017-10-23
P1433published inRadiologyQ3285690
P1476titlePrediction of Therapeutic Effect of Chemotherapy for NSCLC Using Dual-Input Perfusion CT Analysis: Comparison among Bevacizumab Treatment, Two-Agent Platinum-based Therapy without Bevacizumab, and Other Non-Bevacizumab Treatment Groups
P478volume286